Physician profile
Bruce E Ruben
NPI 1740376714
$1,092.00
in general payments reported to CMS, 2019-2025
19 companies · $334 in 2025
The $334 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $112 · 2021: $80.07 · 2022: $87.08 · 2023: $128 · 2024: $182 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $644.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $171.35 | 2020-2025 | Nuzyra |
| Abbvie INC. | $126.16 | 2022-2025 | |
| Melinta Therapeutics, LLC | $120.52 | 2019-2025 | Kimyrsa, Rezzayo |
| Integra Lifesciences Corporation | $117.42 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Merck Sharp & Dohme LLC | $95.53 | 2019-2024 | Recarbrio, Zerbaxa |
| Tetraphase Pharmaceuticals, INC. | $70.33 | 2019 | |
| Smith+Nephew, INC. | $69.55 | 2020-2024 | Collagenase Santyl |
| Takeda Pharmaceuticals U.S.A., INC. | $65.59 | 2023 | Hyqvia, Cuvitru |
| Convatec INC. | $50.94 | 2024-2025 | |
| La Jolla Pharmaceutical Company | $30.10 | 2021-2025 | Zevtera |
| Axsome Therapeutics, INC. | $29.46 | 2023 | Sunosi |
| Angiodynamics, INC. | $26.40 | 2020 | |
| Shionogi INC | $25.48 | 2025 | Fetroja |
| Aimmune Therapeutics, INC. | $25.15 | 2025 | Vowst |
| Invivyd INC | $19.88 | 2025 | Pemgarda |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $15.10 | 2020 | |
| Hydrofera LLC | $12.49 | 2021 | |
| Mayne Pharma Commercial LLC | $11.06 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $9.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Ruben listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.